000 01430 a2200349 4500
005 20250518053547.0
264 0 _c20200205
008 202002s 0 0 eng d
022 _a1879-0720
024 7 _a10.1016/j.ejps.2019.105032
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYuan, Dongfen
245 0 0 _aA systems pharmacokinetic/pharmacodynamic model for concizumab to explore the potential of anti-TFPI recycling antibodies.
_h[electronic resource]
260 _bEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
_cOct 2019
300 _a105032 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_xpharmacokinetics
650 0 4 _aAntibodies, Monoclonal, Humanized
_xpharmacokinetics
650 0 4 _aBlood Coagulation
_xdrug effects
650 0 4 _aEndosomes
_xmetabolism
650 0 4 _aHaplorhini
650 0 4 _aHemophilia A
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLipoproteins
_xmetabolism
650 0 4 _aModels, Biological
650 0 4 _aRabbits
700 1 _aRode, Frederik
700 1 _aCao, Yanguang
773 0 _tEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
_gvol. 138
_gp. 105032
856 4 0 _uhttps://doi.org/10.1016/j.ejps.2019.105032
_zAvailable from publisher's website
999 _c29987479
_d29987479